The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-Del(5q) Myelodysplastic Syndromes: Results From the MDS-005 Study
Clinical Lymphoma, Myeloma and Leukemia- United States
doi 10.1016/j.clml.2017.12.004
Full Text
Abstract
Available in
Date
February 1, 2018
Authors
Publisher
Elsevier BV